Evidence map›Paper›PMID 28637476›Full record

ArticleMicrobial cell factories2017

Eliminating acetate formation improves citramalate production by metabolically engineered Escherichia coli.

Naga Sirisha Parimi, Ian A Durie, Xianghao Wu, Afaq M M Niyas, Mark A Eiteman

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Production of (R)-citramalate by engineeredMetabolic engineering communications · 2024
    Article
  3. Article
  4. Minimizing acetate formation from overflow metabolism inFrontiers in bioengineering and biotechnology · 2024
    Article
  5. Synergetic engineering ofSynthetic and systems biotechnology · 2023
    Article
  6. Ambient temperature CONature communications · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. A Review of the Biotechnological Production of Methacrylic Acid.Frontiers in bioengineering and biotechnology · 2020
    Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Naga Sirisha ParimiSchool of Chemical, Materials and Biomedical Engineering, Driftmier Engineering Center, University of Georgia, Athens, GA, 30602, USA.
Ian A DurieSchool of Chemical, Materials and Biomedical Engineering, Driftmier Engineering Center, University of Georgia, Athens, GA, 30602, USA.
Xianghao WuSchool of Chemical, Materials and Biomedical Engineering, Driftmier Engineering Center, University of Georgia, Athens, GA, 30602, USA.
Afaq M M NiyasSchool of Chemical, Materials and Biomedical Engineering, Driftmier Engineering Center, University of Georgia, Athens, GA, 30602, USA.
Mark A EitemanSchool of Chemical, Materials and Biomedical Engineering, Driftmier Engineering Center, University of Georgia, Athens, GA, 30602, USA. eiteman@engr.uga.edu.
University of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCitramalate, a chemical precursor to the industrially important methacrylic acid (MAA), can be synthesized using Escherichia coli overexpressing citramalate synthase (cimA gene). Deletion of gltA encoding citrate synthase and leuC encoding 3-isopropylmalate dehydratase were critical to achieving high citramalate yields. Acetate is an undesirable by-product potentially formed from pyruvate and acetyl-CoA, the precursors of citramalate during aerobic growth of E. coli. This study investigated strategies to minimize acetate and maximize citramalate production in E. coli mutants expressing the cimA gene.

resultsKey knockouts that minimized acetate formation included acetate kinase (ackA), phosphotransacetylase (pta), and in particular pyruvate oxidase (poxB). Deletion of glucose 6-phosphate dehydrogenase (zwf) and ATP synthase (atpFH) aimed at improving glycolytic flux negatively impacted cell growth and citramalate accumulation in shake flasks. In a repetitive fed-batch process, E. coli gltA leuC ackA-pta poxB overexpressing cimA generated 54.1 g/L citramalate with a yield of 0.64 g/g glucose (78% of theoretical maximum yield), and only 1.4 g/L acetate in 87 h.

conclusionsThis study identified the gene deletions critical to reducing acetate accumulation during aerobic growth and citramalate production in metabolically engineered E. coli strains. The citramalate yield and final titer relative to acetate at the end of the fed-batch process are the highest reported to date (a mass ratio of citramalate to acetate of nearly 40) without being detrimental to citramalate productivity, significantly improving a potential process for the production of this five-carbon chemical.

Indexed as

Metabolic EngineeringAcetatesAcetyl Coenzyme AAerobiosisBatch Cell Culture TechniquesEscherichia coliGene DeletionGenes, BacterialMalatesMutationPyruvic AcidAcetatesAcetyl Coenzyme AcitramalateMalatesPyruvic AcidAcetateAcetyl-CoACitramalateEscherichia coliFed-batchGlucosePyruvate

Identifiers

PMID28637476
PMCPMC5480221
OpenAlexW2651249597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.